All News

Data showed that fracture risk rises briefly after menopausal hormone therapy discontinuation, then falls below never-users.

A new study highlights the strong prognostic value of the 100-g oral glucose tolerance test in identifying pregnant women at high risk for developing diabetes mellitus.

A study found that increased midpregnancy uterine artery resistance may slightly impair executive function in offspring.

A new FDA-submitted self-collection HPV test aims to improve cervical cancer screening access for underserved women by offering a convenient, noninvasive at-home option.

Women who drink heavily are 50% more likely to become pregnant, even when actively trying to avoid it, according to a new study.

Study reveals rising use of antiseizure medications during pregnancy, highlighting risks and trends in maternal health and medication safety.

A recent survey reveals significant gaps in public knowledge about pregnancy health, including misconceptions on weight gain, supplements, and vaccine safety.

A nationwide analysis reveals rural mothers are more likely to receive medication or therapy for postpartum depression and anxiety compared with their urban counterparts.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.

A new review finds immediate release nifedipine offers comparable safety and efficacy to IV labetalol and hydralazine in managing severe hypertension during pregnancy.

A new study reveals Black women have larger, more U-shaped levator hiatus dimensions than White women, highlighting potential implications for pelvic floor disorder.

SARS-CoV-2 infection during pregnancy alters placental gene expression and increases pathology, especially when contracted in the first trimester.

Driven by economic concerns and shifting family planning trends, the US fertility rate dropped below 1.6 births per woman, despite a slight rise in total births.

A new meta-analysis found no significant difference in wound complications between metal staples and subcuticular sutures for post-cesarean skin closure in obese patients.

A new study finds that patient-reported screening methods are highly effective for determining medication abortion eligibility.

A new ACOG clinical guidance offers updated recommendations on umbilical cord management for preterm births based on recent evidence and analysis.

Stephanie Pearson, MD, provides some tips for ergonomics within obstetrics and gynecology.

A new study finds that infections such as chlamydia, gonorrhea, and syphilis during pregnancy significantly increase the risk of stillbirth, preterm birth, and low birth weight.

The World Health Organization’s evidence-based recommendations aim to improve care and outcomes for pregnant women with sickle cell disease.

"The FDA did not raise any concern regarding the general approvability of elinzanetant in its correspondence," according to an anouncement from Bayer.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A new study finds that intrahepatic cholestasis of pregnancy diagnosis before 32-weeks’ gestation increases the risk of adverse outcomes.

Kephera Diagnostics announced the launch of EndomTest, a noninvasive blood test for endometriosis, promising faster diagnoses and improved patient care.

A study finds that a uniform labor induction protocol did not reduce racial disparities in cesarean deliveries or maternal health outcomes.

The FDA has granted priority review to expand flibanserin (Addyi; Sprout Pharmaceuticals) use to postmenopausal women, potentially broadening access to treatment for hypoactive sexual desire disorder.

A new study reveals that stem cell treatment activates oocytes in 70% of women with ovarian failure.

A new study finds that restrictive abortion legislation significantly increases maternal health risks in pregnancies with life-limiting fetal diagnoses.